SCHEMBL6046856

SCHEMBL6046856

COc1cc2ncnc(Nc3[c]ccc(Cl)c3)c2cc1OCCCCN

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EGFR P00533 6/20 0.56
KDR P35968 14/20 0.55
FGFR1 P11362 1/20 0.55
FLT1 P17948 1/20 0.55
FLT4 P35916 1/20 0.55
RET P07949 1/20 0.55
HDAC3 O15379 13/20 0.54
HDAC4 P56524 13/20 0.54
HDAC1 Q13547 13/20 0.54
HDAC7 Q8WUI4 13/20 0.54
HDAC2 Q92769 13/20 0.54
HDAC10 Q969S8 13/20 0.54
HDAC11 Q96DB2 13/20 0.54
HDAC8 Q9BY41 13/20 0.54
HDAC6 Q9UBN7 13/20 0.54
HDAC9 Q9UKV0 13/20 0.54
HDAC5 Q9UQL6 13/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6046884 0.81 KDR (0.63) EGFRKDRFGFR1FLT1FLT4
SCHEMBL5911530 0.79 EGFR (0.80) EGFRKDRFGFR1FLT1RET
Hydrochloric Acid SCHEMBL5911595 0.78 EGFR (0.80) EGFRKDRFGFR1FLT1RET
SCHEMBL5911655 0.77 EGFR (0.86) EGFRKDRFLT4
Hydrochloric Acid SCHEMBL5911498 0.76 EGFR (0.84) EGFRKDRFLT4
SCHEMBL7864752 0.74 FLT1 (0.83) EGFRKDRFGFR1FLT1FLT4
SCHEMBL4109645 0.74 KDR (0.80) EGFRKDRFGFR1FLT1FLT4
SCHEMBL14863005 0.73 EGFR (0.84) EGFRKDRFLT4
SCHEMBL1468310 0.73 FLT1 (0.85) EGFRKDRFGFR1FLT1FLT4
SCHEMBL8258194 0.73 EGFR (0.83) EGFRKDRFGFR1FLT1RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1633365-A1 MACROCYCLIC QUINAZOLINE DERIVATIVES AS ANTIPROLIFERATIVE AGENTS JANSSEN PHARMACEUTICA N.V. (BE) 2006-03-15 EP disclosed
WO-2004105765-A1 MACROCYCLIC QUINAZOLINE DERIVATIVES AS ANTIPROLIFERATIVE AGENTS JANSSEN PHARMACEUTICA N.V. (BE) 2004-12-09 WO disclosed